Estadisticas : Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model

Rodrigo, M.J.
Visitas:688
340 ( Estados Unidos de América )
128 ( Singapur )
93 ( Reino Unido )
47 ( Hong kong )
24 ( Alemania )
16 ( Letonia )
9 ( Togo )
7 ( Irlanda )
5 ( Rusia )
5 ( Austria )
4 ( Finlandia )
3 ( China )
2 ( Francia )
2 ( España )
1 ( Bulgaria )
1 ( Costa de Marfil )
1 ( Suecia )
Descargas: 431